BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29749456)

  • 1. Role of the overexpression of TRAF4 in predicting the prognosis of intrahepatic cholangiocarcinoma.
    Kang Q; Zou H; Zhou L; Liu LX; Cai JB; Xie N; Li WH; Zhang C; Shi WH; Wang LM; Zhang WH; Zhu H; Wang SF; Zhang XW
    Int J Oncol; 2018 Jul; 53(1):286-296. PubMed ID: 29749456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
    Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
    Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of GLS1 in intrahepatic cholangiocarcinoma and its clinical significance.
    Cao J; Zhang C; Jiang GQ; Jin SJ; Gao ZH; Wang Q; Yu DC; Ke AW; Fan YQ; Li DW; Wang AQ; Bai DS
    Mol Med Rep; 2019 Aug; 20(2):1915-1924. PubMed ID: 31257527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery.
    Shi RY; Yang XR; Shen QJ; Yang LX; Xu Y; Qiu SJ; Sun YF; Zhang X; Wang Z; Zhu K; Qin WX; Tang ZY; Fan J; Zhou J
    Cancer; 2013 Mar; 119(5):993-1003. PubMed ID: 23132676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of Capn4 overexpression in intrahepatic cholangiocarcinoma.
    Zhang C; Bai DS; Huang XY; Shi GM; Ke AW; Yang LX; Yang XR; Zhou J; Fan J
    PLoS One; 2013; 8(1):e54619. PubMed ID: 23349941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications.
    Zhang C; Liu LX; Dong ZR; Shi GM; Cai JB; Zhang PF; Ke AW; Yu JX; Zhou J; Fan J
    Tumour Biol; 2015 Mar; 36(3):1781-9. PubMed ID: 25391422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of TRAF4 targeting RSK4 inhibits proliferation, invasion and metastasis in breast cancer xenografts.
    Zhu L; Zhang S; Huan X; Mei Y; Yang H
    Biochem Biophys Res Commun; 2018 Jun; 500(3):810-816. PubMed ID: 29684350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased roundabout 1 expression promotes development of intrahepatic cholangiocarcinoma.
    Mano Y; Aishima S; Fukuhara T; Tanaka Y; Kubo Y; Motomura T; Toshima T; Iguchi T; Shirabe K; Maehara Y; Oda Y
    Hum Pathol; 2013 Nov; 44(11):2419-26. PubMed ID: 23953227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3 overexpression promotes metastasis in intrahepatic cholangiocarcinoma and correlates negatively with surgical outcome.
    Yang XW; Li L; Hou GJ; Yan XZ; Xu QG; Chen L; Zhang BH; Shen F
    Oncotarget; 2017 Jan; 8(5):7710-7721. PubMed ID: 28032598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortalin promotes cell proliferation and epithelial mesenchymal transition of intrahepatic cholangiocarcinoma cells in vitro.
    Kang Q; Cai JB; Dong RZ; Liu LX; Zhang C; Zhang PF; Zou H; Xie N; Zhang L; Zhang XY; Song ZJ; Dong ZR; Hu MY; Huang XY; Zhang XW; Ke AW; Shi GM
    J Clin Pathol; 2017 Aug; 70(8):677-683. PubMed ID: 28096273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch1 is overexpressed in human intrahepatic cholangiocarcinoma and is associated with its proliferation, invasiveness and sensitivity to 5-fluorouracil in vitro.
    Wu WR; Zhang R; Shi XD; Zhu MS; Xu LB; Zeng H; Liu C
    Oncol Rep; 2014 Jun; 31(6):2515-24. PubMed ID: 24700253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma.
    Li H; Zhou ZQ; Yang ZR; Tong DN; Guan J; Shi BJ; Nie J; Ding XT; Li B; Zhou GW; Zhang ZY
    Hepatology; 2017 Jul; 66(1):136-151. PubMed ID: 28194813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRAF4 enhances osteosarcoma cell proliferation and invasion by Akt signaling pathway.
    Yao W; Wang X; Cai Q; Gao S; Wang J; Zhang P
    Oncol Res; 2014; 22(1):21-28. PubMed ID: 25700355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma.
    Xie N; Cai JB; Zhang L; Zhang PF; Shen YH; Yang X; Lu JC; Gao DM; Kang Q; Liu LX; Zhang C; Huang XY; Zou H; Zhang XY; Song ZJ; Sun HX; Fu BM; Ke AW; Shi GM
    Cell Death Dis; 2017 Dec; 8(12):3205. PubMed ID: 29235470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sprouty2 suppresses progression and correlates to favourable prognosis of intrahepatic cholangiocarcinoma via antagonizing FGFR2 signalling.
    Xu YF; Liu HD; Liu ZL; Pan C; Yang XQ; Ning SL; Zhang ZL; Guo S; Yu JM
    J Cell Mol Med; 2018 Nov; 22(11):5596-5606. PubMed ID: 30160357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of P-cadherin overexpression and possible mechanism of its regulation in intrahepatic cholangiocarcinoma and pancreatic cancer.
    Sakamoto K; Imai K; Higashi T; Taki K; Nakagawa S; Okabe H; Nitta H; Hayashi H; Chikamoto A; Ishiko T; Beppu T; Baba H
    Cancer Sci; 2015 Sep; 106(9):1153-62. PubMed ID: 26132727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAP1 acts as a tumor suppressor in intrahepatic cholangiocarcinoma by modulating the ERK1/2 and JNK/c-Jun pathways.
    Chen XX; Yin Y; Cheng JW; Huang A; Hu B; Zhang X; Sun YF; Wang J; Wang YP; Ji Y; Qiu SJ; Fan J; Zhou J; Yang XR
    Cell Death Dis; 2018 Oct; 9(10):1036. PubMed ID: 30305612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma.
    Huang Y; Kong Y; Zhang L; He T; Zhou X; Yan Y; Zhang L; Zhou D; Lu S; Zhou J; Zhou L; Xie H; Zheng S; Wang W
    Biomed Res Int; 2018; 2018():2352139. PubMed ID: 29511671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-21 regulates the invasion and metastasis in cholangiocarcinoma and may be a potential biomarker for cancer prognosis.
    Huang Q; Liu L; Liu CH; You H; Shao F; Xie F; Lin XS; Hu SY; Zhang CH
    Asian Pac J Cancer Prev; 2013; 14(2):829-34. PubMed ID: 23621247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRRK2 Is Associated with Recurrence-Free Survival in Intrahepatic Cholangiocarcinoma and Downregulation of LRRK2 Suppresses Tumor Progress In Vitro.
    Gu S; Chen J; Zhou Q; Yan M; He J; Han X; Qiu Y
    Dig Dis Sci; 2020 Feb; 65(2):500-508. PubMed ID: 31489563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.